Trials / Completed
CompletedNCT06654778
Ultrasound Evaluation of Preventive Measures for Postoperative Lung Atelectasis After Surgery
Ultrasound Evaluation of Different Preventive Measures of Post Operative Lung Atelectasis After Upper Abdominal Surgeries: Ventilation and Fluid Measures
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
the aim of this prospective randomized blinded clinical study will be to assess the ultrasound evaluation of different preventive measures of post operative lung atelectasis in abdominal surgeries; these measures include ventilation and fluid measures
Detailed description
ultrasound evaluation for application of different preventive measures of post operative lung atelectasis, including positive end-expiratory pressure, lung recruitment maneuvers, and restrictive fluid management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | PEEP | Patients will be ventilated with PEEP of 8 cm H2O and fluid management: 500 ml of Ringer's lactate in the recovery room before surgery and Ringer's lactate at a rate of 4 mL/kg/hour from the beginning to the end of the surgery. |
| OTHER | PEEP/RM | Patients will be ventilated with PEEP of 8 cm H2O, and then RM (30 cm H2O for 30 s) will be applied immediately after the second LUS examination and repeated every 30 minutes till emergence and fluid management: 500 ml of Ringer's lactate in recovery room before surgery and Ringer's lactate at a rate of 4 mL/kg/hour from the beginning to the end of the surgery |
| OTHER | PEEP/RM/RF | Patients will be ventilated with PEEP of 8 cm H2O, and then RM (30 cm H2O for 30 s) will be applied immediately after the second LUS examination and repeated every 30 minutes till emergence and restrictive fluid management (RF). Ringer's lactate at a rate of 3 mL/kg/hour from the beginning to the end of the surgery |
Timeline
- Start date
- 2024-12-08
- Primary completion
- 2025-12-19
- Completion
- 2025-12-19
- First posted
- 2024-10-23
- Last updated
- 2025-12-26
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06654778. Inclusion in this directory is not an endorsement.